Form 4: USPH COO Graham Reeve Granted 10,000 Restricted Shares
Insider Transaction Report
U.S. Physical Therapy COO Graham D. Reeve was granted 10,000 shares of restricted common stock, increasing his direct beneficial ownership.
Summary
- Chief Operating Officer (COO) Graham D. Reeve acquired 10,000 shares of common stock in U.S. Physical Therapy Inc. (USPH).
- These shares were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan.
- The acquisition price for these restricted shares was $0.00.
- Following this transaction, Mr. Reeve directly beneficially owns 30,740 shares and indirectly owns 1,808 shares through the Reeve Trust.
- The 10,000 newly granted restricted shares will vest in 15 quarterly installments of 624 shares, beginning on May 20, 2026, and a final installment of 640 shares on March 6, 2030.
- Total restricted shares held by Mr. Reeve, inclusive of this grant, amount to 23,348 shares, with various vesting schedules extending through March 6, 2030, contingent on his continued employment.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive development, as it signifies the company's commitment to retaining and incentivizing a key executive, aligning his interests with long-term shareholder value.
Positives
- Grant of 10,000 restricted shares to COO Graham D. Reeve, aligning executive compensation with long-term shareholder value.
- The shares were granted at a price of $0.00, indicating a direct equity award designed for retention and incentive.
Risks
- Vesting of all restricted stock, including the 10,000 newly granted shares and the previously granted 13,348 shares, is contingent upon Graham D. Reeve's continued employment with U.S. Physical Therapy Inc. through each applicable vesting date.
Future Outlook
The multi-year vesting schedule for the restricted stock indicates a long-term retention strategy for the COO, aiming to align his interests with the company's sustained performance and shareholder value creation over several years.
Management Comments
- The grant of restricted stock to COO Graham D. Reeve reflects the company's strategy to incentivize and retain key executives through long-term equity awards, fostering alignment with shareholder interests.
Industry Context
StockSavvy.ai notes that equity grants to executives are a standard practice in the healthcare services industry, particularly for publicly traded companies like U.S. Physical Therapy, to align management incentives with shareholder interests and promote long-term performance and retention.
Comparison to Industry Standards
- Equity compensation for COOs is a common practice across the healthcare services sector, comparable to companies like Select Medical Holdings Corporation (SEM) or Encompass Health Corporation (EHC), which frequently utilize restricted stock units (RSUs) or stock options to incentivize executive performance and retention.
- The multi-year vesting schedule, extending to 2030, is typical for long-term incentive plans designed to ensure executive commitment over several financial cycles, similar to programs seen at larger healthcare providers.
Related Party Transactions
- Grant of restricted stock to Graham D. Reeve, the Chief Operating Officer, as part of his executive compensation package under the Company's Amended and Restated 2003 Stock Incentive Plan.
Stakeholder Impact
- Shareholders: Potential positive impact due to increased alignment of executive incentives with long-term company performance and stability.
- Employees: No direct impact mentioned, but a stable executive team can contribute to overall company stability and strategic direction.
Next Steps
- Continued employment of Graham D. Reeve to ensure the vesting of restricted shares according to the established schedule.
- Future quarterly vesting events for restricted stock through March 6, 2030, as detailed in the filing.
Key Dates
| Date | Description |
|---|---|
| 02/23/2026 | Date of transaction: Grant of 10,000 restricted shares to COO Graham D. Reeve. |
| 02/25/2026 | Date the Statement of Changes in Beneficial Ownership (Form 4) was signed. |
| March 6, 2026 | Vesting date for 1,964 shares of previously granted restricted stock. |
| May 20, 2026 | First vesting date for 624 shares of the new 10,000 restricted stock grant and 1,948 shares of previously granted restricted stock. |
| August 20, 2026 | Vesting date for 624 shares of the new 10,000 restricted stock grant and 1,948 shares of previously granted restricted stock. |
| November 20, 2026 | Vesting date for 624 shares of the new 10,000 restricted stock grant and 1,948 shares of previously granted restricted stock. |
| March 6, 2027 | Vesting date for 624 shares of the new 10,000 restricted stock grant and 1,956 shares of previously granted restricted stock. |
| May 20, 2027 | Vesting date for 624 shares of the new 10,000 restricted stock grant and 1,636 shares of previously granted restricted stock. |
| August 20, 2027 | Vesting date for 624 shares of the new 10,000 restricted stock grant and 1,636 shares of previously granted restricted stock. |
| November 20, 2027 | Vesting date for 624 shares of the new 10,000 restricted stock grant and 1,636 shares of previously granted restricted stock. |
| March 6, 2028 | Vesting date for 624 shares of the new 10,000 restricted stock grant and 1,640 shares of previously granted restricted stock. |
| May 20, 2028 | Vesting date for 624 shares of the new 10,000 restricted stock grant and 1,130 shares of previously granted restricted stock. |
| August 20, 2028 | Vesting date for 624 shares of the new 10,000 restricted stock grant and 1,130 shares of previously granted restricted stock. |
| November 20, 2028 | Vesting date for 624 shares of the new 10,000 restricted stock grant and 1,130 shares of previously granted restricted stock. |
| March 6, 2029 | Vesting date for 624 shares of the new 10,000 restricted stock grant and 1,134 shares of previously granted restricted stock. |
| May 20, 2029 | Vesting date for 624 shares of the new 10,000 restricted stock grant and 624 shares of previously granted restricted stock. |
| August 20, 2029 | Vesting date for 624 shares of the new 10,000 restricted stock grant and 624 shares of previously granted restricted stock. |
| November 20, 2029 | Vesting date for 624 shares of the new 10,000 restricted stock grant and 624 shares of previously granted restricted stock. |
| March 6, 2030 | Final vesting date for 640 shares of the new 10,000 restricted stock grant and 640 shares of previously granted restricted stock. |
Recommendation
holdThis Form 4 filing details a routine executive compensation event (restricted stock grant) and does not provide new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. It primarily indicates continued executive retention and alignment.
Keywords
USPH, U.S. Physical Therapy, Graham Reeve, Restricted Stock, Stock Grant, Insider Transaction, Form 4, Executive Compensation, COO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.